Catalyst Wire Dossier Catalyst Wire Dossier

Auriclosene

auriclosene · NovaBay Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Auriclosene, covering 2015-05-28 to 2015-05-28. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis [Phase 2]

See pricing